In Phase A, individuals will get different doses and schedules of oral ABBV-744 tablet to establish Secure dosing routine. More individuals will be enrolled with the discovered monotherapy dosign program. In Phase B, participants will obtain oral ruxolitinib and ABBV-744 might be given as "incorporate-on" therapy. In Segment C, participants https://abbv-744cancertreatmentcl03578.mdkblog.com/37822665/what-does-abbv-744-in-clinical-trials-for-non-small-cell-lung-cancer-nsclc-mean